Patients with severe COVID-19 may be at high vascular risk
New guidelines advise thromboprophylaxis
Coagulopathy is emerging as a contributor to decline among patients seriously ill with COVID-19, leading to new recommendations for thromboprophylaxis.
Hospitalised patients may need to be on heparin and should have their risk assessed, say leading Australian haematologists.
